Contents

Search

glecaprevir

Indications: - for use in combination with pibrentasvir (Mavyret) for treatment of chronic hepatitis C Mechanism of action: - NS3/4A protease inhibitor

General

antiviral agent heterocyclic compound, 2 rings

Database Correlations

PUBCHEM cid=66828839

References

  1. Lowes R FDA OKs 8-Week Mavyret for Hepatitis C Medscape - Aug 03, 2017. http://www.medscape.com/viewarticle/883778

Component-of

glecaprevir/pibrentasvir (Mavyret)